Enrollment, retention, and strategies for including disadvantaged populations in randomized controlled trials: a

Abigail LaPlante1,2, Renata W Yen1, Talia Isaacs3

  • 1The Dartmouth Institute for Health Policy & Clinical Practice, Dartmouth College, Williamson Translational Research Building, Level 5, 1 Medical Center Drive, Lebanon, NH, 03756, USA.

Systematic Reviews
|August 19, 2021
PubMed
Abstract

Insights

This systematic review will quantify enrollment metrics and the effectiveness of strategies used to include disadvantaged populations in randomized controlled trials. Findings will highlight recruitment challenges and inform future research for better health equity.

Area of Science:

  • Clinical Trials
  • Health Disparities Research
  • Systematic Review Methodology

Background:

  • Many randomized controlled trials (RCTs) fail to meet sample size targets, leading to underrepresentation of diverse populations.
  • Disadvantaged groups are often omitted or underrepresented in RCTs, limiting the generalizability of findings.
  • Existing policies aim to improve representation, but their effectiveness in RCTs targeting disadvantaged populations is not systematically reviewed.

Purpose of the Study:

  • To systematically review and quantify enrollment metrics in RCTs focused on disadvantaged populations.
  • To evaluate the effectiveness of inclusion and retention strategies for disadvantaged groups in RCTs.
  • To establish baseline data for tracking progress in recruiting diverse populations for health research.

Main Methods:

  • Systematic literature search across multiple databases (EMBASE, MEDLINE, Web of Science, CINAHL) and grey literature.
  • Inclusion of RCTs where at least 50% of participants are defined as disadvantaged.
  • Data extraction and quality assessment by two independent reviewers, with narrative synthesis and potential meta-analysis of recruitment strategies.

Main Results:

  • This section is to be filled after the study's completion.
  • Anticipated results include baseline recruitment and enrollment metrics for trials targeting disadvantaged populations.
  • The review will identify common barriers and effective strategies for including these populations.

Conclusions:

  • Findings will elucidate the scope of challenges in recruiting disadvantaged populations for health intervention research.
  • The study aims to promote research on tailored recruitment strategies and improve health equity in clinical trials.
  • Establishes a foundation for monitoring future improvements in the recruitment of underrepresented groups.

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.3K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
522
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
207
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
182
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K